Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medius Holdings CoTSE:3154 -1.52%59 5-Year Yield-on-Cost % is 3.96 as of Aug. 02, 2026, which is 21% above its 10-year median of 3.28. GuruFocus rates TSE:3154 with a GF Score™ of 59/100 and a GF Value™ of 円744.28 (Fairly Valued). The stock has 6 warning signs investors should review. Among 319 Medical Devices & Instruments companies, Medius Holdings Co ranks better than 68.65% on this metric.
Medius Holdings Co's yield on cost for the quarter that ended in Dec. 2025 was 3.96.
The historical rank and industry rank for Medius Holdings Co's 5-Year Yield-on-Cost % or its related term are showing as below:
TSE:3154'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.58 Med: 3.28 Max: 4.76
Current: 3.96
During the past 13 years, Medius Holdings Co's highest Yield on Cost was 4.76. The lowest was 0.58. And the median was 3.28.
TSE:3154's 5-Year Yield-on-Cost % is ranked better than 68.65% of 319
companies
in the Medical Devices & Instruments industry
Industry Median: 2.44
vs TSE:3154: 3.96
Medius Holdings Co (TSE:3154) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Medius Holdings Co 5-Year Yield-on-Cost % Related Terms
TSE:3154 vs ISRG, BDX, MDLN: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, Medius Holdings Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medius Holdings Co 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medius Holdings Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Medius Holdings Co's 5-Year Yield-on-Cost % falls into.
Medius Holdings Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Medius Holdings Co (TSE:3154) has a 5-Year Yield-on-Cost % of 3.96 as of Aug. 02, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medius Holdings Co and its competitors. This is 21% above median its historical median of 3.28. Over the past decade, Medius Holdings Co's 5-Year Yield-on-Cost % has ranged from 0.58 to 4.76. According to the industry distribution chart, Medius Holdings Co ranks #100 out of 319 companies in the Medical Devices & Instruments industry, placing it in the top 31.3%.
Is Medius Holdings Co's 5-Year Yield-on-Cost % too high?
Medius Holdings Co's current 5-Year Yield-on-Cost % of 3.96 is 21% above median its 10-year median of 3.28. Over the past 10 years, this metric has ranged from a low of 0.58 to a high of 4.76. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.44. Medius Holdings Co's value of 3.96 is 62.3% above this industry median. Based on the distribution chart, Medius Holdings Co ranks #100 out of 319 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medius Holdings Co has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medius Holdings Co's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Medius Holdings Co ranks #100 out of 319 companies for 5-Year Yield-on-Cost %. This puts Medius Holdings Co in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.44. Medius Holdings Co's value of 3.96 is 62.3% above this benchmark. Historically, Medius Holdings Co's own 5-Year Yield-on-Cost % has ranged from 0.58 to 4.76 over the past decade. While the company's 10-year median is 3.28 vs. the industry median of 2.44, Medius Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.44, based on 319 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medius Holdings Co's current 5-Year Yield-on-Cost % of 3.96 is 62.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medius Holdings Co and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medius Holdings Co's current 5-Year Yield-on-Cost % is 3.96, which is 21% above median its own 10-year median of 3.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medius Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Medius Holdings Co (TSE:3154) is currently considered Fairly Valued. The stock's GF Value™ is 円744.28, compared to a current price of 円779.00 — trading 4.7% above its estimated fair value. The current 5-Year Yield-on-Cost % is 3.96, which is 21% above median its 10-year median of 3.28 and 62.3% above the Medical Devices & Instruments industry median of 2.44. Medius Holdings Co's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Medius Holdings Co (TSE:3154), the current 5-Year Yield-on-Cost % is 3.96 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medius Holdings Co (TSE:3154) Overvalued in 2026?
Based on GuruFocus' analysis, Medius Holdings Co stock appears to be overvalued.
The current stock price of 円779.00 is trading 4.7% above its estimated GF Value™ of 円744.28.
GuruFocus considers Medius Holdings Co to be Fairly Valued.
Key valuation signals for TSE:3154:
5-Year Yield-on-Cost %: 3.96 (21% above median its 10-year median of 3.28)
GF Value™: 円744.28 vs. price of 円779.00 (4.7% above fair value)
Industry Position: 62.3% above the Medical Devices & Instruments median (#100 of 319)
No single metric tells the full story. See the TSE:3154 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medius Holdings Co Ltd is engaged in the healthcare sector. The company's business division includes Medical equipment sales business, Care and welfare business, and Solution business. The Medical equipment sales business offers syringes and gloves to surgical assistance along with repairs and maintenance of medical equipment, and The care and welfare business provides transfer equipment and electric powdered beds. The company's segments include: Medical equipment sales business; and Nursing care and welfare business. It derives maximum revenue from Medical equipment sales business.
59GF Score
Get the complete analysis for TSE:3154
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3154 has been successfully added to your 
